Introduction {#sec0005}
============

*Capnocytophaga sputigena* is a capnophilic gram-negative fusiform bacillus belonging to the family Flavobacteriaceae. This bacterium was first described in 1979 and belongs to the normal flora of the subgingival throat \[[@bib0005]\]. There is no national or international epidemiological surveillance of this bacterium. As for pulmonary infections, they still seem very little described. Here, we report a case of pneumonia with *C. sputigena.*

Clinical case {#sec0010}
=============

In July 2018, a 22-year-old woman with a severe obesity, for which she underwent sleeve gastrectomy, was hospitalized in our infectious diseases unit, in the IHU Méditeranée Infection, Marseille, France. For 2 weeks she had rhinorrhoea associated with fever without improvement under symptomatic treatment. Subsequently, symptoms worsened with dyspnoea, coughing, fever and purulent sputum. Amoxicillin was introduced as acute community pneumonia was suspected. After 8 days of antibiotic therapy, the symptoms persisted and led the patient to consult again in the emergency department.

Clinically, she presented cough with sputum associated with crackles at the two pulmonary bases. The rest of the clinical exam was normal. Chest radiograph showed a focal infection of the left lower lung lobe associated with diffuse interstitial syndrome ([Fig. 1](#fig0005){ref-type="fig"}). Standard blood test analysis found moderate inflammatory syndrome with CRP at 45 mg/L without hyperleucocytosis or any other abnormality. On the microbiological level, *Legionella pneumophila* and *Streptococcus pneumoniae* urinary antigens were negative. We decided to empirically change antibiotic therapy for levofloxacin in this atypical pneumonia resistant to amoxicillin.Fig. 1Chest radiograph highlighting a pneumonia.Fig. 1

Three semi-quantitative cultures of sputum specimen were performed, for which *C. sputigena* was found predominant. The isolate identified by MALDI-TOF MS grew at 10^7^CFU/mL in all specimens. Antibiotic susceptibility testing was performed according to the EUCAST recommendations using *Haemophilus* spp. breakpoints and evinced a resistance to amoxicillin and a susceptibility to amoxicillin-clavulanic acid.

According to these results, amoxicillin-clavulanic acid was introduced. In parallel, this atypical case of pneumonia due to *C. sputigena* was documented. The patient entirely recovered after 7 days of treatment.

Discussion {#sec0015}
==========

*C. sputigena* is rarely implicated in pulmonary infection, most of the described cases related its implication in bacteraemia or amniotic infections \[[@bib0010]\]. To the best of our knowledge, only five other cases of *C. sputigena* pulmonary infection have been described ([Table 1](#tbl0005){ref-type="table"}). Infection can occur in immunocompetent hosts, and Lo et al. reported the case of a bilateral pneumonia with pleural effusion in an 84-year-old man. *C. sputigena* was detected on blood cultures \[[@bib0015]\]. Li et al. presented a case of a 68-year-old immunocompetent man with persistent pleural effusion for whom *C. sputigena* was detected on a pleural drain \[[@bib0020]\]. *C. sputigena* has also been involved in a respiratory infection following care; a 67-year-old old man, who underwent fibroscopy for exploration of a suspicious pulmonary mass, presented fever 7 days after the procedure, and a lung abscess was diagnosed. *C. sputigena* was isolated from the latter and histological analysis detected a lung cancer \[[@bib0025]\]. Furthermore, *C. sputigena* was involved in a lung abscess in a 39-year-old immunocompromised host suffering from a neuroendocrine tumor. Interestingly, the biochemical testing identified the isolate as C. *ochracea* or C. *sputigena* \[[@bib0030]\]. Finally, the pediatric population can be affected as Atmani et al. related the case of a 12-year-old girl with pleural effusion involving *C. sputigena* \[[@bib0035]\].Table 1Cases report of *C. sputigena* pulmonary infections previously reported.Table 1Cases reportSexAgePast medical historyImmuno-suppressionClinical presentationPositive culture on\
Detection byTreatmentDeathAtmani S, et al. *Arch Pediatr.*\
2008F12NoneNoFebrile pleural effusionPleural fluid\
16S RNA sequencingAmoxicillin\
RifampicinNoLi A, et al.\
*J Clin Microbiol.* 2013M64Hypertensive intracranial hemorrhage vascular dementia, parotid pleomorphe adenomaNoPleural empyema with unfavorable evolution (treated since one month)Pleural fluid\
MALDI-TOF MS\
(Codetection of\
*P. aeruginosa)*Amoxicillin CiprofloxacinNoLo SH1, et al.\
*J Microbiol Immunol Infect.*\
2017M84Stroke, diapletic seizure, high blood pressure, type 2 diabetic mellitus, benign prostatic hypertrophy, gastric cancerGastric cancer\
Diabetic mellitusRelapsing bilateral pneumonia with pleural effusionBlood culture\
MALDI-TOF MS\
16S RNA sequencingPiperacillin tazobactamNoMigiyama Y, et al.\
*J Infect Chemother.*\
2018M67Prostatic cancerLung cancerLung abscess seven days after fibroscopy for pulmonary mass explorationLung abscess fluid\
MALDI-TOF MSMeropenemNoOur caseF22Severe obesity, sleeve gastrectomyNoPneumoniaSputum\
MALDI-TOF MSAmoxicillin\
Clavulanic acidNo

Our case is the first in which *C. sputigena* is recovered from a sputum specimen. Sputum might be a difficult sample for interpretation and diagnosis of this infection, as the bacterium is a commensal of the oral flora. However, in our case, *C. sputigena* was detected on three samples and with a significant bacterial load. Moreover, clinical response was correlated with antibiotic susceptibility as the introduction of a beta-lactamase inhibitor improved the clinical course. The bacterium was identified by MALDI-TOF mass spectrometry, which is the technique that has been used in recent case reports \[[@bib0015], [@bib0020], [@bib0025]\].

Evolution was unfavourable following amoxicillin treatment. *Capnocytophaga* is now often resistant to beta-lactam because of its beta-lactamase production. Adjunction of a beta-lactam inhibitor is recommended when a treatment against *Capnocytophaga* is initiated \[[@bib0040]\]. As an example, in our lab, since 2013, among the 51 samples found positive for *C. sputigena*, we found that 55% were sensitive to amoxicillin, while 100% were sensitive to amoxicillin-clavulanic acid.

Conclusion {#sec0020}
==========

We present here the first documented case of pneumonia caused by *C. sputigena* after sputum examination, and the second case described in France. The repeated culture of this bacterium from the sputum samples of the same patient should alert microbiologists and infectious disease clinicians, as this bacterium can, in rare occasion, cause pneumonia.
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